検索
LAVA Therapeutics NV
LVTXウォッチリストに追加
1.740USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
45.77M時価総額
損失額直近12ヶ月PER
詳細情報 LAVA Therapeutics NV 企業名
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA Therapeutics NVの企業情報
企業コードLVTX
会社名LAVA Therapeutics NV
上場日Mar 25, 2021
最高経営責任者「CEO」Mr. Stephen A. Hurly
従業員数34
証券種類Ordinary Share
決算期末Mar 25
本社所在地Yalelaan 60
都市UTRECHT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号3584 CM
電話番号31850163100
ウェブサイトhttps://www.lavatherapeutics.com/
企業コードLVTX
上場日Mar 25, 2021
最高経営責任者「CEO」Mr. Stephen A. Hurly
LAVA Therapeutics NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
-100.00%
Mr. Edward F. Smith
Mr. Edward F. Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
よくある質問
LAVA Therapeutics NVの上位5名の株主は誰ですか？
LAVA Therapeutics NVの上位5名の株主は以下のとおりです。Dr. Kapil Dhingra, M.D.
LAVA Therapeutics NV（LVTX）の株式を保有している機関の数はいくつですか？
2025Q4時点で、LAVA Therapeutics NVの株式を保有している機関は49社あり、保有株式の総市場価値は約7.26Mで、全体の27.59%を占めています。2025Q3と比較して、機関の持ち株は-4778197.00増加しています。